He Ying, Cao Yan, Xu Yu-jian, Huang Jian, Sun Zhi-xing, Zhou Zuo-min, Sha Jia-hao, Liu Cheng-yong, Wang Qing, Chi Lei, Yang Xiao-yu
Department of Andrology, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing , Jiangsu 210029, China.
Zhonghua Nan Ke Xue. 2006 Dec;12(12):1135-8.
To investigate the effects of Jujingwan on the spermatozoal ultrastructure and apoptosis of germ cells in oligospermia patients.
We treated 50 oligospermia patients with Jujingwan and observed the spermatozoal ultrastructure, the apoptosis of germ cells and the changes in the DNA ploidy proportion of spermatogenic cells by electron microscopy and FCM before the treatment and 3, 6, 9 and 12 months after it.
Jujingwan increased sperm acrosome base density 6 months after the treatment and remarkably improved the integrity of acrosome membrane 12 months after it, with no obvious pathological changes in the nuclei and tails. Three months after the treatment, cell debris and apoptotic cells decreased significantly as compared with pre-treatment (P < 0. 05) , and very significantly 12 months after the treatment (P <0. 01). The proportion of haploid spermatozoa increased very significantly (P <0.01) , and the lost primary spermatocytes decreased significantly (P <0. 05) compared with pre-treatment.
Jujingwan can increase the density of sperm acrosome base and improve the pathological changes of acrosome membrane in oligospermia patients; it can improve the activity of acrosome enzyme and the integrity of acrosome membrane, decrease the apoptosis rate of germ cells and sperm and increase the percentage of haploid spermatozoa; it can also reduce the percentage of apoptotic bodies and diploid sperm cells. It is indicated that Jujingwan can inhibit the apoptosis of germ cells and sperm and improve spermatogenesis in oligospermia patients.
探讨聚精丸对少精子症患者精子超微结构及生殖细胞凋亡的影响。
采用聚精丸治疗50例少精子症患者,分别于治疗前及治疗后3、6、9、12个月,运用电子显微镜及流式细胞术观察精子超微结构、生殖细胞凋亡及生精细胞DNA倍体比例变化。
治疗6个月后聚精丸可增加精子顶体基部密度,治疗12个月后可显著改善顶体膜完整性,细胞核及尾部无明显病理改变。治疗3个月后,细胞碎片及凋亡细胞较治疗前显著减少(P<0.05),治疗12个月后极显著减少(P<0.01)。单倍体精子比例极显著增加(P<0.01),与治疗前相比,初级精母细胞丢失显著减少(P<0.05)。
聚精丸可增加少精子症患者精子顶体基部密度,改善顶体膜病理改变;可提高顶体酶活性及顶体膜完整性,降低生殖细胞及精子凋亡率,增加单倍体精子百分比;还可降低凋亡小体及二倍体精子细胞百分比。表明聚精丸可抑制少精子症患者生殖细胞及精子凋亡,改善生精功能。